![Christophe Berthoux](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christophe Berthoux
Nessuna posizione attualmente
Profilo
Christophe Berthoux is Chief Executive Officer at Resonant Clinical Solutions, Inc. since 2025.
Chairman at Image Analysis Ltd. since 2018.
Director at Future Meds Ltd. since 2020.
Operating Partner at ArchiMed SAS since 2019.
Former Chief Executive Officer at Synexus Clinical Research Ltd. Former Chief Executive Officer at North American Science Associates LLC.
Former Director at genOway SA. Former Chief Commercial Officer & EVP-Global Sales at Charles River Laboratories Edinburgh Ltd. Education includes a doctorate from the University of Pennsylvania and graduate studies at Purdue University.
Posizioni attive di Christophe Berthoux
| Società | Posizione | Inizio |
|---|---|---|
Image Analysis Ltd.
 Image Analysis Ltd. Internet Software/ServicesTechnology Services Operates a cloud-based platform that provides medical imaging services and analytical software | Presidente | 02/10/2018 |
ArchiMed SAS
 ArchiMed SAS Investment ManagersFinance ArchiMed invests in small and middle-sized companies located across the globe. The firm targets companies operating in the field of the healthcare sector. It participates in growth and buyout transactions with an investment size of EUR 10 - 1000 million. The firm makes follow-on investments. | Investitore di Private Equity | 01/09/2019 |
Future Meds Ltd.
 Future Meds Ltd. Miscellaneous Commercial ServicesCommercial Services Operates research sites which provides patient recruitment and clinical trial management services | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Christophe Berthoux
| Società | Posizione | Fine |
|---|---|---|
North American Science Associates LLC
 North American Science Associates LLC Miscellaneous Commercial ServicesCommercial Services Provides medical device testing, preclinical and clinical research & regulatory compliance consulting services | Amministratore Delegato | - |
Charles River Laboratories Edinburgh Ltd.
 Charles River Laboratories Edinburgh Ltd. Pharmaceuticals: MajorHealth Technology Provides scientific research services | Vendite & Marketing | - |
| GENOWAY | Direttore/Membro del Consiglio | - |
Synexus Clinical Research Ltd.
 Synexus Clinical Research Ltd. Medical/Nursing ServicesHealth Services Offers clinical trials and biological research services | Amministratore Delegato | - |
Formazione di Christophe Berthoux
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
52
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Synexus Clinical Research Ltd.
Synexus Clinical Research Ltd. Medical/Nursing ServicesHealth Services Offers clinical trials and biological research services | Health Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Charles River Laboratories Edinburgh Ltd.
Charles River Laboratories Edinburgh Ltd. Pharmaceuticals: MajorHealth Technology Provides scientific research services | Health Technology |
genOway SA
 genOway SA BiotechnologyHealth Technology Develops gene technology | Health Technology |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
North American Science Associates LLC
North American Science Associates LLC Miscellaneous Commercial ServicesCommercial Services Provides medical device testing, preclinical and clinical research & regulatory compliance consulting services | Commercial Services |
ArchiMed SAS
ArchiMed SAS Investment ManagersFinance ArchiMed invests in small and middle-sized companies located across the globe. The firm targets companies operating in the field of the healthcare sector. It participates in growth and buyout transactions with an investment size of EUR 10 - 1000 million. The firm makes follow-on investments. | Finance |
Image Analysis Ltd.
Image Analysis Ltd. Internet Software/ServicesTechnology Services Operates a cloud-based platform that provides medical imaging services and analytical software | Technology Services |
Future Meds Ltd.
Future Meds Ltd. Miscellaneous Commercial ServicesCommercial Services Operates research sites which provides patient recruitment and clinical trial management services | Commercial Services |
